James Rouse has been appointed president and chief operating officer of Arrhythmia Research Technology (Fitchburg, Massachusetts). Rouse was named president of Micron Products, a wholly owned subsidiary of Arrhythmia, earlier this year following positions as plant manager and general manager. Arrhythmia Research Technology sells and licenses medical equipment that analyzes heart impulses through signal-averaging electrocardiographic software.
Bradford Gay has been named president and chief executive officer of Boston Medical Technologies (Wakefield, Massachusetts), replacing John Schafer, who will continue to serve the company in a consulting role. Boston Medical is the developer of the Anscore Health Management System, a noninvasive system for the measurement of heart rate variability.
Bruce MacKinnon has been appointed manager of new business development at CardioTech International (CDT; Woburn, Massachusetts). In a related move, Ricci Smelser has been promoted to the new position of engineering manager. MacKinnon has held sales positions at Westinghouse, Honeywell and Archer Daniels Midland. Smelser has been with CardioTech for more than a decade in various technical positions. CDT is a maker of catheters for various medical uses, along with delivery systems and balloon-expandable products.
Keith Reisinger has been named corporate vice president, technology, at Edwards Lifesciences (Irvine, California). Additionally, Todd Abraham has been named vice president, manufacturing. Reisinger most recently served as vice president and chief operating officer for medical technology start-up Transurgical, and as vice president of Miravant Medical Technologies. Abraham most recently was vice president and general manager of medical device start-up Sterilis. Edwards Lifesciences is a developer of advanced cardiovascular disease treatments.
Donna Edmonds has been named senior vice president of sales and marketing at Ischemia Technologies (Denver, Colorado). Most recently, Edmonds was with Spectral Diagnostics, where she was responsible for launching that company's Cardiac STATus product line. Ischemia Technologies develops diagnostic tests for ischemia based on detection of the biochemical marker ischemia modified albumin.
Stephen Oesterle, MD, has been named senior vice president of medicine and technology for Medtronic (Minneapolis, Minnesota). Oesterle will join the company in January 2002 and succeed Glen Nelson, MD, who is retiring next March. Oesterle is currently associate professor of medicine at the Harvard University Medical School and director of invasive cardiology services at Massachusetts General Hospital.
Matthew Hooper was promoted to vice president, general counsel, of Scios (Sunnyvale, California). He replaces John Newman, who has retired after serving as general counsel since 1983. Hooper has been the senior patent counsel handling all intellectual property matters and drafting key contracts. Scios is a biopharmaceutical company developing treatments for cardiovascular and inflammatory disease.
Patrick Nestor has been appointed general manager for first responder and public access defibrillation at Zoll Medical (Burlington, Massachusetts). Most recently, Nestor was director of sales for CAS medical Systems. Zoll makes noninvasive cardiac resuscitation devices.